We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 723 results
  1. Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy

    Purpose

    To explore the effects of pegvisomant (PEGV) on glucose metabolism in patients with acromegaly within ACROSTUDY, an international,...

    Thierry Brue, Anders Lindberg, ... Cecilia Camacho-Hübner in Endocrine
    Article Open access 24 November 2018
  2. Consensus on criteria for acromegaly diagnosis and remission

    Purpose

    The 14th Acromegaly Consensus Conference was convened to consider biochemical criteria for acromegaly diagnosis and evaluation of therapeutic...

    Andrea Giustina, Nienke Biermasz, ... Maria Chiara Zatelli in Pituitary
    Article Open access 03 November 2023
  3. Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly

    Introduction

    Treatment of acromegaly resistant to first generation somatostatin analogues (first gen-SSA) is often difficult. We aimed to investigate...

    Sabrina Chiloiro, Denise Costa, ... Laura De Marinis in Endocrine
    Article Open access 20 August 2022
  4. Conventional X-rays in the diagnosis and follow-up of vertebral fractures in patients with acromegaly: a real-life study

    Objectives

    To explore the role of conventional X-ray imaging in detecting vertebral fractures (VFs) in patients with acromegaly, both at diagnosis of...

    C. Sardella, C. Urbani, ... F. Bogazzi in Journal of Endocrinological Investigation
    Article 05 September 2023
  5. Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy

    Objective

    This study aimed to assess the long-term outcome of patients with acromegaly.

    Design

    This is a multicenter, retrospective, observational...

    M. Arosio, V. Sciannameo, ... G. Reimondo in Journal of Endocrinological Investigation
    Article Open access 12 January 2024
  6. Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients?

    Introduction

    Acromegaly is a rare but potentially life-threatening disease, if not promptly managed, for the systemic complications due to the...

    Sabrina Chiloiro, Antonella Giampietro, ... Antonio Bianchi in Endocrine
    Article 29 November 2022
  7. Giant growth hormone-secreting pituitary adenomas from the endocrinologist’s perspective

    Objectives

    Since giant (≥40 mm) GH-secreting pituitary adenomas are rarely encountered, data on their characteristics and treatment outcomes are...

    Bahadir Koylu, Busra Firlatan, ... Tomris Erbas in Endocrine
    Article 01 November 2022
  8. New findings on brain actions of growth hormone and potential clinical implications

    Growth hormone (GH) is secreted by somatotropic cells of the anterior pituitary gland. The classical effects of GH comprise the stimulation of cell...

    Jose Donato Jr., John J. Kopchick in Reviews in Endocrine and Metabolic Disorders
    Article 07 December 2023
  9. Growth Hormone and Counterregulation in the Pathogenesis of Diabetes

    Purpose of Review

    Canonical growth hormone (GH)-dependent signaling is essential for growth and counterregulatory responses to hypoglycemia, but also...

    Xuehong Dong, Lei Su, Mary-Elizabeth Patti in Current Diabetes Reports
    Article 24 August 2022
  10. Klinisch aktive Hypophysentumoren

    The widespread use of diagnostic imaging has led to an increase in the incidence of pituitary tumors. The majority of incidentalomas are...

    Nicole Unger, Marily Theodoropoulou, Katharina Schilbach in Die Innere Medizin
    Article 13 June 2024
  11. Acromegaly increases depressive symptoms and reduces quality of life of cohabitants

    Purpose

    To assess how living with patients with acromegaly affects people’s psychology and quality of life (QoL).

    Methods

    Acromegaly patients and...

    Serhat Uysal, Cem Sulu, ... Pinar Kadioglu in Pituitary
    Article 30 December 2023
  12. Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life

    Purpose

    Current treatment of acromegaly restores a normal life expectancy in most cases. So, the study of persistent complications affecting patients’...

    Biagio Cangiano, Emanuele Giusti, ... Francesco Trimarchi in Endocrine
    Article Open access 02 July 2022
  13. Newer parameters of the octreotide test in patients with acromegaly

    Purpose

    Predicting the therapeutic effects of first-generation somatostatin receptor ligands (fg-SRLs) is important when assessing or planning...

    Shin Urai, Masaaki Yamamoto, ... Wataru Ogawa in Pituitary
    Article 24 November 2023
  14. Non-serious case reports

    Article 02 December 2023
  15. Cabergoline/lanreotide

    Article 14 October 2023
  16. Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System

    Background and objective

    Evidence highlights the allergenic potential of PEGylated drugs because of the production of anti-polyethylene glycol...

    Salvatore Crisafulli, Paola Maria Cutroneo, ... Gianluca Trifirò in Drug Safety
    Article Open access 15 February 2023
  17. Cabergoline

    Article 29 April 2023
  18. Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases

    Pituitary adenomas are rare in children and young people under the age of 19 (hereafter referred to as CYP) but they pose some different diagnostic...

    Márta Korbonits, Joanne C. Blair, ... Helen A. Spoudeas in Nature Reviews Endocrinology
    Article 09 February 2024
Did you find what you were looking for? Share feedback.